Source Record

  • Full Name: The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication (Rask-Andersen, Masuram, Schioth 2014) Version: January-2014

Genes

Total: 1016
In Groups: 1013
Inter-Gene Interactions: 0

Drugs

Total: 2419
In Groups: 1872

Interactions

Total: 5063

Full Citation

The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication. Rask-Andersen M, Masuram S, Schioth HB. Annu Rev Pharmacol Toxicol. 2014;54:9-26. doi: 10.1146/annurev-pharmtox-011613-135943. PMID: 24016212